199 Potent T cell costimulation mediated by a novel costimulatory antigen receptor (CoStAR) with dual CD28/CD40 signaling domains to improve adoptive cell therapies

• Robert Hawkins,
• Gray Kueberuwa,
• Milena Kalaitsidou,
• John Bridgeman,
• Rubén Alvarez-Rodríguez,
• Martina Sykorova,
• Leyuan Bao,
• Cynthia Chauvin-Fleurence,
• Michelle Le Brocq

Affiliations

Robert Hawkins

Aff1 grid.412917.80000000404309259Department of Medical OncologyChristie NHS Foundation Trust Manchester United Kingdom

Gray Kueberuwa

Aff1 0000000121662407grid.5379.8Clinical and Experimental Immunotherapy Group, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Division of Cancer SciencesThe University of Manchester Wilmslow Road, Withington M20 4QL Manchester UK

Milena Kalaitsidou

Instil Bio, Inc., Dallas, TX, USA

John Bridgeman

Instil Bio, Inc., Dallas, TX, USA

Rubén Alvarez-Rodríguez

Instil Bio, Inc., Dallas, TX, USA

Martina Sykorova

Instil Bio, Inc., Dallas, TX, USA

Leyuan Bao

Instil Bio, Inc., Dallas, TX, USA

Cynthia Chauvin-Fleurence

Instil Bio, Inc., Dallas, TX, USA

Michelle Le Brocq

Instil Bio, Inc., Dallas, TX, USA